Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS

被引:2
作者
Foxwell, AR [1 ]
Cripps, AW
机构
[1] Univ Canberra, Gadi Res Ctr Med & Hlth Sci, Canberra, ACT 2601, Australia
[2] Griffith Univ, Sch Med, Gold Coast, Qld, Australia
关键词
D O I
10.1016/S0140-6736(04)16535-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2102 / 2103
页数:2
相关论文
共 12 条
[1]   EVALUATION OF BOVINE, COLD-ADAPTED HUMAN, AND WILD-TYPE HUMAN PARAINFLUENZA TYPE-3 VIRUSES IN ADULT VOLUNTEERS AND IN CHIMPANZEES [J].
CLEMENTS, ML ;
BELSHE, RB ;
KING, J ;
NEWMAN, F ;
WESTBLOM, TU ;
TIERNEY, EL ;
LONDON, WT ;
MURPHY, BR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (06) :1175-1182
[2]  
CRIPPS AW, 1999, MUCOSAL IMMUNOLOGY, P253
[3]   Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines [J].
Crowe, JE ;
Firestone, CY ;
Murphy, BR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3910-3918
[4]   PROTECTION FROM LETHAL CORONAVIRUS INFECTION BY AFFINITY-PURIFIED SPIKE GLYCOPROTEIN OF MURINE HEPATITIS-VIRUS, STRAIN-A59 [J].
DANIEL, C ;
TALBOT, PJ .
VIROLOGY, 1990, 174 (01) :87-94
[5]   Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong [J].
Donnelly, CA ;
Ghani, AC ;
Leung, GM ;
Hedley, AJ ;
Fraser, C ;
Riley, S ;
Abu-Raddad, LJ ;
Ho, LM ;
Thach, TQ ;
Chau, P ;
Chan, KP ;
Lam, TH ;
Tse, LY ;
Tsang, T ;
Liu, SH ;
Kong, JHB ;
Lau, EMC ;
Ferguson, NM ;
Anderson, RM .
LANCET, 2003, 361 (9371) :1761-1766
[6]   A LIVE ATTENUATED BOVINE PARAINFLUENZA VIRUS TYPE-3 VACCINE IS SAFE, INFECTIOUS, IMMUNOGENIC, AND PHENOTYPICALLY STABLE IN INFANTS AND CHILDREN [J].
KARRON, RA ;
WRIGHT, PF ;
HALL, SL ;
MAKHENE, M ;
THOMPSON, J ;
BURNS, BA ;
TOLLEFSON, S ;
STEINHOFF, MC ;
WILSON, MH ;
HARRIS, DO ;
CLEMENTS, ML ;
MURPHY, BR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1107-1114
[7]   RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE [J].
KIM, HW ;
CANCHOLA, JG ;
BRANDT, CD ;
PYLES, G ;
CHANOCK, RM ;
JENSEN, K ;
PARROTT, RH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :422-+
[8]   Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates [J].
Schmidt, AC ;
McAuliffe, JM ;
Huang, A ;
Surman, SR ;
Bailly, JE ;
Elkins, WR ;
Collins, PL ;
Murphy, BR ;
Skiadopoulos, MH .
JOURNAL OF VIROLOGY, 2000, 74 (19) :8922-8929
[9]   Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3 [J].
Schmidt, AC ;
McAuliffe, JM ;
Murphy, BR ;
Collins, PL .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4594-4603
[10]  
Schmidt AC, 2002, J VIROL, V76, P1089, DOI [10.1128/JVI.76.23.12355-12359.2002, 10.1128/JVI.76.3.1089-1099.2002]